|
Re: New, effective and less toxic therapeutic option for patients with HER2-positive
You are right, of course. And I've told others the same - that soon the term "breast cancer' will be obsolete.
I should drop the term myself and help move science along, eh?
The better question, GDP, is what drugs can we expect to cross over from research of other initial cancer sites? Prostate, colorectal cancers, ovarian?
I looked at PECAM-1 and read it has a function of getting rid of old neutrophils. This is interesting to me because my hubby has large granular lymphocytosis and has an almost non existant neutrophil count. I suspect that my breast cancer came from his cancer, but my body responds in a different way. I know that it seemed to hijack my immune system, but it didn't affect my neutrophil count. I just feel it used something in my system to evade destruction.
__________________
Diagnosed 2007
Stage IIb Invasive Ductal Carcinoma, Pagets, 3 of 15 positive nodes
Traditional Treatment: Mastectomy and Axillary Node Dissection followed by Taxotere, 6 treatments and 1 year of Herceptin, no radiation
Former Chemo Ninja "Takizi Zukuchiri"
Additional treatments:
GP2 vaccine, San Antonio Med Ctr
Prescriptive Exercise for Cancer Patients
ENERGY Study, UCSD La Jolla
Reconstruction: TRAM flap, partial loss, Revision
The content of my posts are meant for informational purposes only. The medical information is intended for general information only and should not be used in any way to diagnose, treat, cure, or prevent disease
|